Ashland Inks Deal to Sell Avoca Business to Optimize Portfolio
Portfolio Pulse from
Ashland is selling its Avoca business, which includes its Sclareolide operations, to Mane as part of its strategy to optimize its portfolio.
December 30, 2024 | 4:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ashland is divesting its Avoca business, including the Sclareolide operations, to Mane. This move is part of Ashland's strategy to optimize its portfolio.
The sale of the Avoca business is a strategic move by Ashland to optimize its portfolio, which could lead to a more focused business strategy and potentially improve financial performance. This is likely to be viewed positively by investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100